American Headache Society Annual Meeting

The latest news from the AHS annual meeting along with researcher interviews and clinician insight.
SPONSORED CONTENT
June 21, 2022
1 min read
Save

Endocannabinoid deficiency may play a role in migraine

DENVER — There may be a link between migraine and clinical endocannabinoid deficiency, a speaker said at the American Headache Society’s annual scientific meeting.

SPONSORED CONTENT
June 21, 2022
5 min watch
Save

VIDEO: HDAC6 inhibitor shown to be effective migraine treatment

DENVER – Treatment with histone deacetylase 6 inhibitor restored neurol complexities and decreased migraine symptoms, Amynah Pradhan, PhD, said at the American Headache Society’s annual scientific meeting.

SPONSORED CONTENT
June 20, 2022
2 min watch
Save

VIDEO: Individualized therapy for migraine still needed

DENVER – More data are still needed on proper dosing of patients with eptinezumab for migraine prevention, Rami Apelian, MD, MPH, FAES, said at the American Headache Society’s annual scientific meeting.

SPONSORED CONTENT
June 17, 2022
5 min watch
Save

VIDEO: Pilot study yields wide range of effective, tolerable verapamil doses for migraine

DENVER — Verapamil was shown to be tolerable for migraine prevention at a maximum dose of 20 mg to 480 mg per day, Yi-Chieh Chen, PharmD, said at the American Headache Society’s annual scientific meeting.

SPONSORED CONTENT
June 16, 2022
1 min watch
Save

VIDEO: Child’s self-report of migraine may differ from diagnostic criteria

DENVER — A child’s understanding of a migraine may not align with diagnostic criteria, highlighting the need for greater transparency in defining “migraine day,” Danielle Kellier, BS, said at the American Headache Society’s annual meeting.

SPONSORED CONTENT
June 16, 2022
2 min watch
Save

VIDEO: Migraine prevalence stable, burden on rise throughout U.S.

DENVER — Although migraine prevalence has remained stable over the past 30 years, measures of burden, including MIDAS scores, have steadily increased, Fred Cohen, MD, said at the American Headache Society’s annual scientific meeting.

SPONSORED CONTENT
June 15, 2022
1 min watch
Save

VIDEO: Several factors apply when selecting patients for clinical trials, expert says

DENVER — In this Healio video, Jessica Ailani, MD, explains that patient selection for clinical trials is not a one-size-fits-all process.

SPONSORED CONTENT
June 15, 2022
2 min watch
Save

VIDEO: Wearable migraine treatment Nerivio shows ‘persistent efficacy’ in patients

DENVER — Nerivio, a noninvasive digital therapeutic device, provided migraine pain relief within 2 hours in 67% of adults and 71% of adolescents, Alon Ironi said at the American Headache Society’s annual scientific meeting.

SPONSORED CONTENT
June 14, 2022
3 min watch
Save

VIDEO: Atrial fibrillation more likely to accompany migraine with aura

DENVER – Individuals who had migraine with aura were more likely to have atrial fibrillation compared with those who had a migraine without aura, a presenter said at the American Headache Society annual meeting.

SPONSORED CONTENT
June 13, 2022
1 min read
Save

Fewer monthly migraine days observed after 6 months of Vyepti vs. placebo

DENVER — Treatment with Vyepti was associated with a sustained reduction in the frequency of episodic and chronic migraines over 6 months, researchers reported at the American Headache Society annual scientific meeting.